Sow Good Seeks 1-for-2 to 1-for-99 Reverse Split Authority Ahead of Any Nasdaq Deficiency
SOWG sits 94% above its 52-week low of $1.04.
Summary
Sow Good's preliminary proxy asks shareholders to approve a reverse split of 1-for-2 up to 1-for-99 so the Board can act quickly if Nasdaq threatens delisting — a live risk because the April 2026 1-for-15 split already used up the usual cure period. The remaining proposals are routine director, auditor and pay votes.
Key Events · Corporate Governance and Compliance · SOWG
-
Reverse Split Authority Sought
Shareholders will vote December 17, 2026 on a charter amendment permitting a reverse split of not less than 1-for-2 and not more than 1-for-99, with the exact ratio left to the Board's discretion for up to two years.
-
No Cure Period Left on Nasdaq
Because the company effected a 1-for-15 reverse split on April 23, 2026, Nasdaq Rule 5810(c)(3)(A)(iv) would require a delisting determination — with no compliance period — if the bid price again falls below $1.00 for 30 consecutive business days within one year of that split.
-
Share Count and Split Math
Based on 41,166,235 shares outstanding at the October 27, 2026 record date, the split would leave roughly 20,583,117 shares at 1-for-2, 4,116,623 at 1-for-10, and 415,820 at the maximum 1-for-99.
-
Board Slate and Auditor Vote
Five nominees — Yisroel Goldberg, Binyomin Posen, Joseph Labkowski, Jack Wortzman and David Natan — stand for election, and shareholders vote on ratifying Urish Popeck & Co. as FY2026 auditor, which billed $115,000 in audit fees for 2025.
Analysis · SOWG · Manufacturing
Sow Good is asking shareholders at the December 17, 2026 annual meeting to pre-authorize a reverse split of anywhere from 1-for-2 to 1-for-99, with the Board picking the exact ratio later. The reason is structural: the company already did a 1-for-15 reverse split on April 23, 2026, and under Nasdaq Rule 5810(c)(3)(A)(iv) a second failure of the $1.00 bid price within a year of that split would trigger an immediate delisting determination with no 180-day cure period. Getting approval now means the Board can act the day a deficiency notice arrives instead of waiting on a shareholder vote. The stock trades at $2.02, so the near-term bid-price risk is not acute, but the company has $8,492 of cash and a $5.2 million working capital deficit per the Q2 2026 10-Q, and a reverse split does nothing to fix that. The rest of the proxy is routine: five director nominees, ratification of Urish Popeck as auditor, and a say-on-pay vote on 2025 compensation that included $1.25 million and $1.15 million severance payments to the former Executive Chairman and CEO.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SOWG was trading at $2.02 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $40.6M. The 52-week trading range was $1.04 to $15.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.